drugset / Trial / NCT05375539
AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients
Phase 1
Completed
12 enrolled
Milton S. Hershey Medical Center
National Cancer Institute (NCI) · collab
NaSequentialOpen-labelTreatment
Summary
This study is to obtain acute dose safety and pharmacokinetics/pharmacodynamics (PK/PD) data in a dose-response trial in prostate cancer patients.
Timeline
- Start
- 2023-05-02
- Primary completion
- 2025-02-15
- Completion
- 2025-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INM176 | Traditional medicine (herbal / TCM) | 800 mg | — |
| Subject | INM176 | Traditional medicine (herbal / TCM) | 1200 mg | — |
| Subject | INM176 | Traditional medicine (herbal / TCM) | 1600 mg | — |